On February 14th, 2023, Durango Boot® proudly presented a 2022 donation of $3,910.00 to the Stefanie Spielman Fund for Breast Cancer Research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). The contribution continues Durango®’s commitment to breast cancer research, bringing the brand’s lifetime donation to $273,184. “Breast cancer research is a cause that Durango ® has been committed to for over a decade,” commented Erin DeLong, Durango ®Boots marketing manager. “We look to support and align with local institutions, such as the Stefanie Spielman Foundation, who are helping those affected by breast cancer. Our team is truly honored to continue to support the Stefanie Spielman Foundation through our Pink Ribbon Boots, to ultimately give cancer the boot, one pair at a time.” Durango® has two styles that directly contribute towards breast cancer research and awareness. The Lady Rebel™ Pink Ribbon Boot (RD3557) is a pink 10-inch full-grain leather pull-on style that features a small pink ribbon logo on each pull tab and a translucent pink ribbon graphic on the outsole. Additionally, last year Durango introduced the 12-inch Western Pink Ribbon Sepia Blush Crush™ Boot (DRD0438), which features faux leather and an embroidered pink ribbon on the pull tab and on the full-grain leather accessory strap with antiqued metal hardware. These two Durango ® Pink Ribbon boots are available at select retailers nationwide, as well as on our website.
About the Stefanie Spielman Fund
In 1998, Stefanie Spielman was diagnosed with breast cancer at the age of 30 and lost her battle with the disease in 2009. Stefanie and her husband Chris Spielman, an All-Star linebacker from Massillon, Ohio and 11-year NFL player, became advocates for the fight against breast cancer, founding the Stefanie Spielman Fund for Breast Cancer Research in 1998. The fund has raised more than $22 million to support research at the OSUCCC – James. To learn more about the Stefanie Spielman Fund for Breast Cancer Research, visit www.spielmanfund.com.
About the OSUCCC – James
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, please visit cancer.osu.edu.